Daiwa Securities Group
AXDX icon

Daiwa Securities Group’s Accelerate Diagnostics AXDX Stock Holding History

Daiwa Securities Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100
Closed -$11K – 1181
2019
Q2 		$11K Sell
100
-30
-23% -$5.87K ﹤0.01% 1049
2019
Q1 		$41K Buy
+130
New +$24.4K ﹤0.01% 958
2018
Q4 		– Sell
-132
Closed -$56K – 1147
2018
Q3 		$56K Buy
132
+40
+43% +$8.84K ﹤0.01% 964
2018
Q2 		$68K Buy
92
+19
+26% +$4.25K ﹤0.01% 969
2018
Q1 		$60K Buy
+73
New +$19.2K ﹤0.01% 951

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Belpointe Asset Management
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Daiwa Securities Group's AXDX Position: Q2 2022 in Review

Daiwa Securities Group sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,579 shares — an estimated $23K sold.

Daiwa Securities Group first reported a position in AXDX in Q1 2018 and held it in 6 quarters. The position peaked at $780K in Q2 2018. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Daiwa Securities Group reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 1,579 Accelerate Diagnostics shares in Q2 2022, an estimated $23K.
  • Daiwa Securities Group first reported a position in Accelerate Diagnostics in Q1 2018 and held it in 6 quarters.
  • Daiwa Securities Group's Accelerate Diagnostics position peaked at $780K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.